title: Human immune reconstitution with spleen cells in SCID/Beige mice.
abstract: BACKGROUND
  We developed an original experimental model to study chronic vascular rejection (CVR) consisting of a graft of human mesenteric artery followed by human immune reconstitution into CB.17 SCID/Beige mice. Human immune reconstitution achieved after human PBMC injection has often been variable and incomplete. The aim of this work was to develop an alternative method to achieve a complete, functional human immune reconstitution.
  
  
  METHODS
  After institutional authorizations, spleen cells were recovered from cadaveric organ donors. Single intraperitoneal injections of various doses of spleen cells were made into 70 CB.17 SCID/Beige mice. Reconstitution of the human immune system was monitored by flow cytometry (circulating human cells) and ELISA (human IgG). Colonization of murine lymphoid organs by human cells was studied by immunohistochemistry and flow cytometry. Evaluation of the immune function consisted of examination of CVR lesions in human arterial grafts. The animals were humanely killed at day 28.
  
  
  RESULTS
  After injection of 30 to 40 x 10(6) spleen cells, the mice showed significant human CD3(+), CD19(+), and CD56(+) populations in peripheral blood. The mean human cells levels were, respectively, 8.2% +/- 5.4%, 2.9% +/- 1.2%, and 5.3% +/- 5.1%. Murine spleen and mesenteric lymph nodes were colonized by human T and B cells, while the murine thymus was only colonized by human T cells. Human IgG was detected in murine serum (65.9 +/- 63.3 mg/L) and typical CVR lesions were observed within the allogeneic grafts.
  
  
  CONCLUSIONS
  Intraperitoneal injection of 30 to 40 x 10(6) human spleen cells into CB.17 SCID/Beige mice induces complete and functional human immune reconstitution allowing the study of CVR under human allogeneic conditions.
authors.affiliation: Inserm U466, CHU Rangueil, Toulouse, France.
authors.forename: B
authors.initials: B
authors.lastname: Marcheix
authors.forename: H
authors.initials: H
authors.lastname: Yacoub-Youssef
authors.forename: D
authors.initials: D
authors.lastname: Calise
authors.forename: J-C
authors.initials: JC
authors.lastname: Thiers
authors.forename: H
authors.initials: H
authors.lastname: Benoist
authors.forename: N
authors.initials: N
authors.lastname: Blaes
authors.forename: B
authors.initials: B
authors.lastname: Ségui
authors.forename: M
authors.initials: M
authors.lastname: Thomsen
authors.forename: C
authors.initials: C
authors.lastname: Dambrin
mesh_terms: D000368:Aged; D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood; D015703:Antigens, CD / Q000097:blood; D002102:Cadaver; D005434:Flow Cytometry; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008198:Lymph Nodes / Q000276:immunology; D017710:Lymphocyte Transfusion; D008297:Male; D008638:Mesenteric Arteries / Q000637:transplantation*; D051379:Mice; D016513:Mice, SCID; D013154:Spleen / Q000276:immunology; D014019:Tissue Donors; D014183:Transplantation, Heterologous / Q000276:immunology*
chemical_list: D000910:Antibodies, Heterophile; D015703:Antigens, CD; D007074:Immunoglobulin G